PURE Bioscience (OTCMKTS:PURE – Get Free Report) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.07 and traded as high as $0.0798. PURE Bioscience shares last traded at $0.0798, with a volume of 3,662 shares traded.
PURE Bioscience Price Performance
The company has a market capitalization of $9.10 million, a PE ratio of -2.33 and a beta of 0.27. The company’s 50 day simple moving average is $0.07 and its 200 day simple moving average is $0.07.
PURE Bioscience Company Profile
PURE Bioscience, Inc develops and commercializes antimicrobial products based on its proprietary silver dihydrogen citrate (SDC) technology. The company’s formulations are designed to provide broad-spectrum antimicrobial activity while supporting applications where effective sanitation and surface treatment are required.
Its product portfolio has included disinfectants, sanitizers and antimicrobial solutions for hard-surface cleaning, food processing, healthcare, hospitality, institutional and commercial environments.
See Also
- Five stocks we like better than PURE Bioscience
- Lennar’s Earnings Miss May Be Sending a Bigger Warning About U.S. Housing
- Priced for a Pullback or More Gains? These 3 Stocks Are Testing the Limits
- These 3 Agentic AI Stocks Have More Than Hype Behind Their Growth Stories
- Not Just Banks: 3 Trading Stocks to Watch After the Fed Rate Hike
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
